Kenneth J Colley

Title: Innovations of Kenneth J Colley in Transdermal Drug Delivery

Introduction

Kenneth J Colley is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of transdermal drug delivery. With a total of four patents to his name, Colley's work focuses on innovative methods for administering active compounds through the skin.

Latest Patents

Colley's latest patents include a transdermal delivery device having a delayed onset. This device features a reservoir containing an active compound, which remains separate from the delivery layers until administration. At the time of administration, the reservoir is either laminated to the delivery layers or ruptured, allowing the active compound, vehicle, and/or permeation enhancers to contact the delivery layers. This results in the administration of the active compound to the skin after a delay period. Another significant patent is the transdermal drug delivery device using an unfilled microporous membrane. This device exhibits a delay period of at least six hours and comprises a laminated composite with multiple layers designed to effectively disperse the drug once the pressure rupturable layer is activated.

Career Highlights

Throughout his career, Kenneth J Colley has worked with various companies, including Cygnus Therapeutic Systems and Farmos Group Ltd. His experience in these organizations has contributed to his expertise in developing advanced drug delivery systems.

Collaborations

Colley has collaborated with notable individuals in the field, including Gary W Cleary and Donald R Wilson. These collaborations have likely enhanced his innovative approaches to transdermal drug delivery.

Conclusion

Kenneth J Colley's contributions to transdermal drug delivery through his innovative patents demonstrate his commitment to advancing medical technology. His work continues to influence the field and improve patient care through effective drug administration methods.